OQROGet OQRO Pro
Insider trade

Mirum Pharmaceuticals (MIRM)PRESIDENT AND COO sold ~$152K

Peter Radovich, PRESIDENT AND COO at Mirum Pharmaceuticals, sold ~$152K of Mirum Pharmaceuticals shares.

~$152K
Approx. value · 3,177 sh @ $47.92
30K
Holds after · shares reported
Traded
Jan 24, 2025
Filed
Jan 27, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 7, 2025Insider · 3 peopleInsiders: 3 sales (~$438K)
  2. Jan 17, 2025InsiderOfficer sold ~$320K of MIRM shares in the open market
  3. Jan 24, 2025 · this disclosureInsiderOfficer sold ~$152K of MIRM shares in the open market

What came next

  1. Jan 24, 2025Insider · 2 peopleInsiders: 2 sales (~$371K)
  2. Feb 3, 2025Insider · 3 peopleInsiders: 3 sales (~$617K)
  3. Mar 3, 2025Insider · 1 personInsiders: 2 sales (~$1.9M)
  4. Mar 4, 2025Insider · 2 peopleInsiders: 2 purchases (~$61K), 2 sales (~$677K)
  5. Mar 5, 2025InsiderDirector purchased ~$12K of MIRM shares in the open market
  6. Mar 6, 2025InsiderDirector purchased ~$59K of MIRM shares in the open market
  7. Mar 7, 2025InsiderDirector purchased ~$25K of MIRM shares in the open market
  8. Mar 10, 2025Insider · 1 personInsiders: 2 purchases (~$57K)
  9. Mar 11, 2025InsiderDirector purchased ~$42K of MIRM shares in the open market
  10. Mar 14, 2025InsiderDirector purchased ~$23K of MIRM shares in the open market
  11. Mar 17, 2025Insider · 4 peopleInsiders: 1 purchase (~$923), 6 sales (~$4.1M)
  12. Mar 18, 2025InsiderOfficer sold ~$107K of MIRM shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Mirum Pharmaceuticals

For Mirum Pharmaceuticals, OQRO holds 6 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MIRM page.

Other recent filings by Peter Radovich, PRESIDENT AND COO

The full history of Peter Radovich, PRESIDENT AND COO is on the profile page.

How this filing works

Other disclosures at Mirum Pharmaceuticals

Everything OQRO holds on this company is on its MIRM page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data